149 related articles for article (PubMed ID: 35561523)
61. Human papillomaviruses target the double-stranded RNA protein kinase pathway.
Hebner CM; Wilson R; Rader J; Bidder M; Laimins LA
J Gen Virol; 2006 Nov; 87(Pt 11):3183-3193. PubMed ID: 17030851
[TBL] [Abstract][Full Text] [Related]
62. Proinflammatory cytokine TNFα promotes HPV-associated oral carcinogenesis by increasing cancer stemness.
Hong HS; Akhavan J; Lee SH; Kim RH; Kang MK; Park NH; Shin KH
Int J Oral Sci; 2020 Jan; 12(1):3. PubMed ID: 31911577
[TBL] [Abstract][Full Text] [Related]
63. mTOR inhibition prevents rapid-onset of carcinogen-induced malignancies in a novel inducible HPV-16 E6/E7 mouse model.
Callejas-Valera JL; Iglesias-Bartolome R; Amornphimoltham P; Palacios-Garcia J; Martin D; Califano JA; Molinolo AA; Gutkind JS
Carcinogenesis; 2016 Oct; 37(10):1014-25. PubMed ID: 27538837
[TBL] [Abstract][Full Text] [Related]
64. Detection of human papillomavirus DNA in malignant lesions from Chinese women with carcinomas of the upper genital tract.
Ip SM; Wong LC; Xu CM; Cheung AN; Tsang PC; Ngan HY
Gynecol Oncol; 2002 Oct; 87(1):104-11. PubMed ID: 12468350
[TBL] [Abstract][Full Text] [Related]
65. Protein intrinsic disorder and human papillomaviruses: increased amount of disorder in E6 and E7 oncoproteins from high risk HPVs.
Uversky VN; Roman A; Oldfield CJ; Dunker AK
J Proteome Res; 2006 Aug; 5(8):1829-42. PubMed ID: 16889404
[TBL] [Abstract][Full Text] [Related]
66. Long non-coding RNA SOX21-AS1 modulates lung cancer progress upon microRNA miR-24-3p/PIM2 axis.
Wang F; Gu T; Chen Y; Chen Y; Xiong D; Zhu Y
Bioengineered; 2021 Dec; 12(1):6724-6737. PubMed ID: 34511042
[TBL] [Abstract][Full Text] [Related]
67. Genomic Signatures in HPV-Associated Tumors.
Hussain SS; Lundine D; Leeman JE; Higginson DS
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696429
[TBL] [Abstract][Full Text] [Related]
68. Hallmarks of HPV carcinogenesis: The role of E6, E7 and E5 oncoproteins in cellular malignancy.
Estêvão D; Costa NR; Gil da Costa RM; Medeiros R
Biochim Biophys Acta Gene Regul Mech; 2019 Feb; 1862(2):153-162. PubMed ID: 30707946
[TBL] [Abstract][Full Text] [Related]
69. PreTect HPV-Proofer: real-time detection and typing of E6/E7 mRNA from carcinogenic human papillomaviruses.
Molden T; Kraus I; Skomedal H; Nordstrøm T; Karlsen F
J Virol Methods; 2007 Jun; 142(1-2):204-12. PubMed ID: 17379322
[TBL] [Abstract][Full Text] [Related]
70. Papillomavirus infections--a major cause of human cancers.
zur Hausen H
Biochim Biophys Acta; 1996 Oct; 1288(2):F55-78. PubMed ID: 8876633
[TBL] [Abstract][Full Text] [Related]
71. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers.
Gillison ML; Koch WM; Capone RB; Spafford M; Westra WH; Wu L; Zahurak ML; Daniel RW; Viglione M; Symer DE; Shah KV; Sidransky D
J Natl Cancer Inst; 2000 May; 92(9):709-20. PubMed ID: 10793107
[TBL] [Abstract][Full Text] [Related]
72. E6 proteins from high-risk HPV, low-risk HPV, and animal papillomaviruses activate the Wnt/β-catenin pathway through E6AP-dependent degradation of NHERF1.
Drews CM; Case S; Vande Pol SB
PLoS Pathog; 2019 Apr; 15(4):e1007575. PubMed ID: 31002735
[TBL] [Abstract][Full Text] [Related]
73. Long noncoding RNA SOX21-AS1 regulates the progression of triple-negative breast cancer through regulation of miR-520a-5p/ORMDL3 axis.
Liu X; Song J; Kang Y; Wang Y; Chen A
J Cell Biochem; 2020 Nov; 121(11):4601-4611. PubMed ID: 32277517
[TBL] [Abstract][Full Text] [Related]
74. Comparison Between HPV DNA Testing and HPV E6/E7 MRNA Testing in Women with Squamous Cell Abnormalities of the Uterine Cervix.
Dabeski D; Duvlis S; Basheska N; Antovska V; Stojovski M; Trajanova M; Dimitrov G; Dabeski A; Gureva-Gjorgievska N
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2019 May; 40(1):51-58. PubMed ID: 31152639
[TBL] [Abstract][Full Text] [Related]
75. microRNAs are biomarkers of oncogenic human papillomavirus infections.
Wang X; Wang HK; Li Y; Hafner M; Banerjee NS; Tang S; Briskin D; Meyers C; Chow LT; Xie X; Tuschl T; Zheng ZM
Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4262-7. PubMed ID: 24591631
[TBL] [Abstract][Full Text] [Related]
76. DNA vaccines for cervical cancer: from bench to bedside.
Hung CF; Monie A; Alvarez RD; Wu TC
Exp Mol Med; 2007 Dec; 39(6):679-89. PubMed ID: 18160838
[TBL] [Abstract][Full Text] [Related]
77. Long non-coding RNA SOX21-AS1 sponges miR-145 to promote the tumorigenesis of colorectal cancer by targeting MYO6.
Wei AW; Li LF
Biomed Pharmacother; 2017 Dec; 96():953-959. PubMed ID: 29217166
[TBL] [Abstract][Full Text] [Related]
78. MicroRNA-18a targeting of the STK4/MST1 tumour suppressor is necessary for transformation in HPV positive cervical cancer.
Morgan EL; Patterson MR; Ryder EL; Lee SY; Wasson CW; Harper KL; Li Y; Griffin S; Blair GE; Whitehouse A; Macdonald A
PLoS Pathog; 2020 Jun; 16(6):e1008624. PubMed ID: 32555725
[TBL] [Abstract][Full Text] [Related]
79. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
80. LINC01101 and LINC00277 expression levels as novel factors in HPV-induced cervical neoplasia.
Iancu IV; Anton G; Botezatu A; Huica I; Nastase A; Socolov DG; Stanescu AD; Dima SO; Bacalbasa N; Plesa A
J Cell Mol Med; 2017 Dec; 21(12):3787-3794. PubMed ID: 28767188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
